U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4398143981Safety and Pharmacokinetic (PK) Study to Assess Bronchopulmonary Disposition of IV Eravacycline (TP-434) in Healthy Men and WomenCompletedNo Results AvailableNormal Drug ToleranceDrug: TP-434 (Eravacycline) reconstituted and administered via an IV infusionhttps://ClinicalTrials.gov/show/NCT01989949
4398243982Eletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral SumatriptanCompletedNo Results AvailableMigraine With or Without AuraDrug: Placebo|Drug: Eletriptan 40 mg|Drug: Eletriptan 80 mghttps://ClinicalTrials.gov/show/NCT01989936
4398343983Smoking Cessation in Women With Gynecological ConditionsActive, not recruitingNo Results AvailableCervical DysplasiaOther: Nicotine Replacement Therapy|Device: Electronic Cigaretteshttps://ClinicalTrials.gov/show/NCT01989923
4398443984Compare the Efficacy and Safety of Raltegravir Versus Efavirenz Combination Therapy in Treatment-naïve HIV-1 PatientsRecruitingNo Results AvailableHIV-1 InfectionDrug: Raltegravir|Drug: Efavirenzhttps://ClinicalTrials.gov/show/NCT01989910
4398543985Effect of HSA or Saline Diluent on Immunotherapy Extract Stability as Determined by Graded ID Skin TestsRecruitingNo Results AvailableAllergic RhinitisDrug: saline with 1mg/ml Histamine base|Drug: diluent, saline with HSA--phenolhttps://ClinicalTrials.gov/show/NCT01989897
4398643986An Efficacy Study Of Ortataxel In Recurrent GlioblastomaRecruitingNo Results AvailableGlioblastomaDrug: Ortataxelhttps://ClinicalTrials.gov/show/NCT01989884
4398743987Adjusted Individual Oral Feeding for Improving Short and Long Term Outcomes of Preterm InfantsNot yet recruitingNo Results AvailableBody Weight Changes|Feeding and Eating Disorders of Childhood|Breast Feeding|Evoked Response AudiometryBehavioral: Adjusted individual feedinghttps://ClinicalTrials.gov/show/NCT01989871
4398843988ITACA-S2 (Intergroup Trial in Adjuvant Chemotherapy for Adenocarcinoma of the Stomach)TerminatedNo Results AvailableGastric AdenocarcinomaOther: peri-operative cht|Other: post-operative CHT|Other: peri-operative cht + post-operative cht-rtx|Other: post-operative cht + post-operative cht-rtxhttps://ClinicalTrials.gov/show/NCT01989858
4398943989Rivaroxaban for the Prevention of Venous Thromboembolism in Asian Patients With CancerRecruitingNo Results AvailableRivaroxaban|Cancer-associated Thrombosis|Recurrence|BleedingDrug: Rivaroxabanhttps://ClinicalTrials.gov/show/NCT01989845
4399043990Pharmaco-economical Study in Kidney TransplantationRecruitingNo Results AvailableRenal Transplanthttps://ClinicalTrials.gov/show/NCT01989832
4399143991Primary Sjögren SyndromeRecruitingNo Results AvailablePrimary Sjögren's SyndromeOther: skin biopsyhttps://ClinicalTrials.gov/show/NCT01989819
4399243992Robotic-assisted Locomotor Training on Mobility and Cardiopulmonary Function in Patients Suffering From Spinal Cord InjuryRecruitingNo Results AvailableSpinal Cord InjuryDevice: Robotic-assisted body weight supported treadmill training (Lokomat V6, Hocoma AG, Switzerland)|Device: Passive lower limbs mobilization training (Motomed Vivo 2, RECK, Germany)https://ClinicalTrials.gov/show/NCT01989806
4399343993A Study of Muscle Strength Maintenance in Older AdultsRecruitingNo Results AvailableSarcopeniaDrug: Losartan|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01989793
4399443994Bevacizumab Plus Paclitaxel Optimization Study With Interventional Maintenance Endocrine Therapy in Advanced or Metastatic ER-positive Human Epidermal Growth Factor Receptor 2(HER2)-Negative Breast CancerRecruitingNo Results AvailableMetastatic Breast CancerDrug: Paclitaxel|Drug: Bevacizumab|Drug: Letrozole|Drug: Anastrozole|Drug: Exemestane|Drug: Fulvestrant|Drug: Goserelin|Device: leuprorelin acetatehttps://ClinicalTrials.gov/show/NCT01989780
4399543995Application of Psychiatric Knowledge in the Rehabilitation Process in Return to Work.CompletedNo Results AvailableMental DisordersBehavioral: control Rehabilitation as usual|Behavioral: educationhttps://ClinicalTrials.gov/show/NCT01989767
4399643996A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusActive, not recruitingNo Results AvailableDiabetes Mellitus, Type 2|AlbuminuriaDrug: Placebo|Drug: Canagliflozin, 100 mg|Drug: Canagliflozin, 300 mghttps://ClinicalTrials.gov/show/NCT01989754
4399743997Effect of Sleep Restriction on Decision Making and InflammationCompletedNo Results AvailableSleep DeprivationOther: Sleep restrictionhttps://ClinicalTrials.gov/show/NCT01989741
4399843998Prevalence and Effect of Detecting Common Mental Disorders in Long-term Sickness AbsenceCompletedNo Results AvailablePsychiatric Disorders|Common Mental Disorders|Depression|Anxiety|Somatoform DisorderProcedure: psychiatric examination and feedbackhttps://ClinicalTrials.gov/show/NCT01989728
4399943999Body Posture Assessment Considering Jaws Position Before and After Orthognathic Surgery on Adult Patient.RecruitingNo Results AvailableOrthognathic SurgeryOther: analyzing the position of the body, muscle activityhttps://ClinicalTrials.gov/show/NCT01989715
4400044000Effect of a Probiotic-based Product on Blood PressureCompletedNo Results AvailableBlood PressureOther: Fermented blueberry drink|Other: Placebo drink|Other: Sachets with probiotic bacterial powder|Other: Sachets with placebo powderhttps://ClinicalTrials.gov/show/NCT01989702
4400144001Etanercept and Vascular Function in PsoriasisCompletedHas ResultsPSORIASISDrug: Etanercept|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01989689
4400244002A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)RecruitingNo Results AvailableMetastatic Breast CancerBiological: PF-05280014|Drug: Paclitaxel|Biological: Herceptin®|Drug: Paclitaxelhttps://ClinicalTrials.gov/show/NCT01989676
4400344003A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04CompletedNo Results AvailableHIVDrug: 1% vaginally applied tenofovir gel|Drug: Tenofovir film- 10mg|Drug: Tenofovir Film-40 mghttps://ClinicalTrials.gov/show/NCT01989663
4400444004The Effect of Taking Break During Colonoscopy Session on Adenoma Detection, a Prospective, Randomized Control StudyCompletedNo Results AvailableColonic AdenomaOther: Break|Other: No breakhttps://ClinicalTrials.gov/show/NCT01989650
4400544005Effect of Strawberries on Cardiovascular Disease RiskCompletedNo Results AvailableCardiovascular DiseaseDietary Supplement: Strawberry Meal|Dietary Supplement: Control Mealhttps://ClinicalTrials.gov/show/NCT01989637
4400644006PAncreatic Adenocarcinoma in HospitalRecruitingNo Results AvailablePancreatic Adenocarcinomahttps://ClinicalTrials.gov/show/NCT01989624
4400744007Implementation of the Pre-Exposure Prophylaxis (PrEP) to HIV: A Demonstrative Project.RecruitingNo Results AvailablePrevention and Control|Preventive Measures|Preventive Therapy|Prophylaxis|HIV Not Infected SubjectsDrug: emtricitabine (FTC) / tenofovir (TDF)https://ClinicalTrials.gov/show/NCT01989611
4400844008Trametinib and Akt Inhibitor GSK2141795 in Treating Patients With Relapsed or Refractory Multiple MyelomaRecruitingNo Results AvailableRecurrent Plasma Cell Myeloma|Refractory Plasma Cell MyelomaDrug: Akt Inhibitor GSK2141795|Other: Laboratory Biomarker Analysis|Other: Pharmacological Study|Drug: Trametinibhttps://ClinicalTrials.gov/show/NCT01989598
4400944009Dabrafenib, Trametinib, and Navitoclax in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by SurgeryRecruitingNo Results AvailableAdult Solid Neoplasm|Recurrent Melanoma|Stage IIIA Skin Melanoma|Stage IIIB Skin Melanoma|Stage IIIC Skin Melanoma|Stage IV Skin MelanomaDrug: Dabrafenib|Other: Laboratory Biomarker Analysis|Biological: Navitoclax|Other: Pharmacological Study|Drug: Trametinibhttps://ClinicalTrials.gov/show/NCT01989585
4401044010Sargramostim and/or Vaccine Therapy in Preventing Disease Recurrence in Patients With Advanced MelanomaCompletedHas ResultsLocal Recurrence of Malignant Melanoma of Skin|Stage IV MelanomaBiological: sargramostim|Biological: peptide vaccine|Other: GM-CSF placebo|Other: peptide placebohttps://ClinicalTrials.gov/show/NCT01989572

* Görseller ve İçerik tekif hakkına sahip olabilir